Literature DB >> 2041597

Is there a premorbid personality typical for Parkinson's disease?

G W Paulson1, N Dadmehr.   

Abstract

For decades clinicians have postulated a characteristic preexisting personality in patients who develop Parkinson's disease (PD). They are described as moralistic, law-abiding, conscientious, and averse to risk-taking. The limited personality surveys tend to be confirmatory, but most of the literature is anecdotal or replete with unprovable psychodynamic postulates. In addition to an apparent stability of marriages and lack of alcoholism, patients with PD are less likely than controls to be smokers. It has been suggested that nicotine and its byproducts are not actually protective against PD, and it could be postulated that higher-than-average intrinsic dopamine may facilitate addiction. Smoking for the patient who is later to develop PD may be particularly unrewarding. In addition, the postulated personality for PD may predispose to hard work, perspiration, and increased exposure to putative trace elements in the water supply.

Entities:  

Mesh:

Year:  1991        PMID: 2041597     DOI: 10.1212/wnl.41.5_suppl_2.73

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

Review 2.  Early Parkinson's disease: what is the best approach to treatment.

Authors:  A H Hristova; W C Koller
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

3.  A prospective study of alcoholism and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Giancarlo Logroscino; Luis A García Rodríguez
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 4.  The personality associated with Parkinson's disease.

Authors:  M Menza
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

5.  Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.

Authors:  P A Schulte; C A Burnett; M F Boeniger; J Johnson
Journal:  Am J Public Health       Date:  1996-09       Impact factor: 9.308

6.  Treatment of Parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system.

Authors:  Tessy López; José L Bata-García; Dulce Esquivel; Emma Ortiz-Islas; Richard Gonzalez; Jorge Ascencio; Patricia Quintana; Gerko Oskam; Fernando J Alvarez-Cervera; Francisco J Heredia-López; José L Góngora-Alfaro
Journal:  Int J Nanomedicine       Date:  2010-12-16

7.  Deletion of alpha-synuclein decreases impulsivity in mice.

Authors:  Y Peña-Oliver; V L Buchman; J W Dalley; T W Robbins; G Schumann; T L Ripley; S L King; D N Stephens
Journal:  Genes Brain Behav       Date:  2011-12-29       Impact factor: 3.449

Review 8.  The role of early life environmental risk factors in Parkinson disease: what is the evidence?

Authors:  Giancarlo Logroscino
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

9.  Personality traits and the risk for Parkinson disease: a prospective study.

Authors:  Johanna Sieurin; Petter Gustavsson; Caroline Elise Weibull; Adina Leiah Feldman; Giselle Maria Petzinger; Margaret Gatz; Nancy Lee Pedersen; Karin Wirdefeldt
Journal:  Eur J Epidemiol       Date:  2015-07-01       Impact factor: 8.082

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.